Market overview
The global isolator market is worth USD 1.5 bn in 2026 and is forecast to reach USD 3.2 bn by 2036, growing at a 8.2% CAGR. United States is the largest country market and Aseptic filling and sterility testing is the largest by application segment.
| Scope | Aseptic and containment isolators, including sterility-test isolators, barrier isolators and glovebox systems, used for sterile drug filling, cell therapy, hazardous drug compounding and laboratories. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.4 bn |
| Value 2026 | USD 1.5 bn |
| Value 2036 | USD 3.2 bn |
| CAGR 2026-2036 | 8.2% |
| Volume 2026 | 6,948 units |
| Volume 2036 | 13,167 units |
| Average price 2026 | USD 210,800 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Isolator market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.5 bn |
| 2027 | USD 1.6 bn |
| 2028 | USD 1.7 bn |
| 2029 | USD 1.9 bn |
| 2030 | USD 2.0 bn |
| 2031 | USD 2.2 bn |
| 2032 | USD 2.4 bn |
| 2033 | USD 2.5 bn |
| 2034 | USD 2.8 bn |
| 2035 | USD 3.0 bn |
| 2036 | USD 3.2 bn |
Isolator market segmentation
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Aseptic filling and sterility testing | 46.0% | 43.0% | USD 674 mn | 7.5% |
| Containment of potent compounds | 24.0% | 21.4% | USD 352 mn | 7.0% |
| Cell and gene therapy | 14.0% | 20.6% | USD 205 mn | 12.4% |
| Compounding and radiopharmacy | 16.0% | 15.0% | USD 234 mn | 7.5% |
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Rigid-wall isolators | 62.0% | 59.4% | USD 908 mn | 7.7% |
| Flexible-film isolators | 16.0% | 17.1% | USD 234 mn | 8.9% |
| Gloveboxes and hybrid systems | 22.0% | 23.5% | USD 322 mn | 8.9% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmaceutical manufacturers | 44.0% | 40.0% | USD 644 mn | 7.2% |
| Biotechnology firms | 20.0% | 24.0% | USD 293 mn | 10.2% |
| Contract manufacturers | 22.0% | 22.0% | USD 322 mn | 8.2% |
| Hospitals and academia | 14.0% | 14.0% | USD 205 mn | 8.2% |
By pressure regime
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Positive pressure | 46.0% | 42.0% | USD 674 mn | 7.2% |
| Negative pressure | 36.0% | 38.0% | USD 527 mn | 8.8% |
| Switchable | 18.0% | 20.0% | USD 264 mn | 9.3% |
By decontamination
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vaporised hydrogen peroxide | 62.0% | 64.0% | USD 908 mn | 8.5% |
| Peracetic acid and chlorine dioxide | 16.0% | 16.0% | USD 234 mn | 8.2% |
| Ozone and ultraviolet | 22.0% | 20.0% | USD 322 mn | 7.2% |
Top 25 countries for isolator by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.0% of 2026 revenue and the 25 countries below together hold 95.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 469 mn | 32.0% | USD 1.0 bn | 7.9% |
| 2 | Germany | USD 132 mn | 9.0% | USD 258 mn | 6.9% |
| 3 | China | USD 132 mn | 9.0% | USD 370 mn | 10.9% |
| 4 | Switzerland | USD 88 mn | 6.0% | USD 180 mn | 7.5% |
| 5 | United Kingdom | USD 73 mn | 5.0% | USD 151 mn | 7.5% |
| 6 | France | USD 73 mn | 5.0% | USD 142 mn | 6.8% |
| 7 | Italy | USD 66 mn | 4.5% | USD 129 mn | 6.9% |
| 8 | Japan | USD 66 mn | 4.5% | USD 122 mn | 6.4% |
| 9 | India | USD 59 mn | 4.0% | USD 180 mn | 11.9% |
| 10 | South Korea | USD 44 mn | 3.0% | USD 103 mn | 8.9% |
| 11 | Spain | USD 18 mn | 1.2% | USD 39 mn | 7.8% |
| 12 | Canada | USD 18 mn | 1.2% | USD 39 mn | 7.8% |
| 13 | Ireland | USD 18 mn | 1.2% | USD 39 mn | 7.8% |
| 14 | Netherlands | USD 16 mn | 1.1% | USD 33 mn | 7.8% |
| 15 | Belgium | USD 16 mn | 1.1% | USD 33 mn | 7.8% |
| 16 | Singapore | USD 16 mn | 1.1% | USD 42 mn | 10.2% |
| 17 | Denmark | USD 13 mn | 0.9% | USD 28 mn | 7.8% |
| 18 | Brazil | USD 10 mn | 0.7% | USD 28 mn | 10.3% |
| 19 | Sweden | USD 10 mn | 0.7% | USD 22 mn | 7.9% |
| 20 | Australia | USD 10 mn | 0.7% | USD 22 mn | 7.9% |
| 21 | Austria | USD 10 mn | 0.7% | USD 22 mn | 7.9% |
| 22 | Taiwan | USD 10 mn | 0.7% | USD 22 mn | 7.9% |
| 23 | Russia | USD 7.8 mn | 0.5% | USD 16 mn | 7.8% |
| 24 | Mexico | USD 7.8 mn | 0.5% | USD 21 mn | 10.3% |
| 25 | Israel | USD 7.8 mn | 0.5% | USD 16 mn | 7.8% |
| Rest of world | USD 74 mn | 5.0% | USD 158 mn | 7.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Getinge
- Skan
- Azbil Telstar
- Syntegon
- Optima Packaging Group
- Fedegari
Group 2: Regional and specialist players
- Comecer
- Tema Sinergie
- Esco Lifesciences
- Germfree
- Metall+Plastic
- Franz Ziel
- Bioquell
- ILC Dover
Group 3: Emerging and niche players
- Envair
- Extract Technology
- Cleatech
- Vanrx Pharmasystems
- Piercan
- Aseptic Enclosures
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the isolator market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.2% is calculated from the resulting values.
The market is divided by application, by type, by end user, by pressure regime, by decontamination. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the isolator market?
The global isolator market is estimated at USD 1.4 bn in 2025 and USD 1.5 bn in 2026.
How fast will the isolator market grow?
It is forecast to reach USD 3.2 bn by 2036, a compound annual growth rate of 8.2% from 2026, an increase of USD 1.8 bn.
Which country is the largest market for isolator?
United States is the largest market by revenue at USD 469 mn in 2026, 32.0% of the global total. The three largest countries together hold 50.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.9% a year from 2026 to 2036.
Which isolator segment is largest?
In the by application split, Aseptic filling and sterility testing is the largest segment with 46.0% of 2026 revenue.
Who are the leading isolator companies?
Global leaders include Getinge, Skan, Azbil Telstar, Syntegon.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- 3D Imaging Surgical SolutionUSD 1.5 bn · 8.5% CAGR
- Neurosurgery & Spine RobotsUSD 1.4 bn · 12.0% CAGR
- Vascular Thromboembolic Disease ThrombectomyUSD 1.5 bn · 13.0% CAGR
- Animal Immunoassay KitsUSD 1.5 bn · 7.0% CAGR
- Muscle Stimulation DevicesUSD 1.4 bn · 5.8% CAGR
- Organ Preservation & Perfusion ProductsUSD 1.4 bn · 11.0% CAGR
- Blister MachineUSD 1.4 bn · 5.5% CAGR
- NebulizerUSD 1.5 bn · 6.0% CAGR
← Isokinetic Diagnostic and Training System Kidney Transplant Rejection Biomarker →